REQUEST A DEMO
Total
USD $0.00
Search more companies

Glenmark Pharmaceuticals Colombia S.A.S. (Colombia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Glenmark Pharmaceuticals Colombia S.A.S. Profile Updated: April 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Glenmark Pharmaceuticals Colombia S.A.S. is an enterprise located in Colombia, with the main office in Bogota D.C.. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. Glenmark Pharmaceuticals Colombia S.A.S. was incorporated on October 15, 2008. There are currently 21 (2024) people employed by Glenmark Pharmaceuticals Colombia S.A.S.. The latest financial highlights indicate a net sales revenue increase of 31.76% in 2023. Its total assets grew by 8.88% over the same period.

Headquarters
Calle 98 # 8 - 36 Oficina 203
Bogota D.C.; Bogota D.C; Postal Code: 0810

Contact Details: Purchase the Glenmark Pharmaceuticals Colombia S.A.S. report to view the information.

Basic Information
Total Employees:
Purchase the Glenmark Pharmaceuticals Colombia S.A.S. report to view the information.
Outstanding Shares:
Purchase the Glenmark Pharmaceuticals Colombia S.A.S. report to view the information.
Incorporation Date:
October 15, 2008
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Fiscal Inspector
Ownership Details
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Glenmark Pharmaceuticals Colombia S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
31.76%
Total operating revenue
31.76%
Operating profit (EBIT)
N/A
Net Profit (Loss) for the Period
N/A
Total assets
8.88%
Total equity
36.47%
Operating Profit Margin (ROS)
N/A
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Quick Ratio
1.76%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?